LifeWatch AG

EANS-Adhoc: +++ Reminder +++ LifeWatch AG to report on positive Q2 2010 results on Thursday, July 29, 2010

@@start.t1@@--------------------------------------------------------------------------------   ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide   distribution. The issuer is solely responsible for the content of this   announcement. --------------------------------------------------------------------------------@@end@@

6-month report/LifeWatch AG

19.07.2010

- 07:00 a.m. CEST: Press release/Letter to Shareholders; - 10:00 a.m. CEST: Analyst/Media Conference; Conference Call/Webcast;

Neuhausen am Rheinfall / Switzerland - LifeWatch AG (SIX Swiss Exchange: LIFE) will report on its positive second quarter 2010 results on Thursday, July 29, 2010, by issuing a Press Release and Letter to Shareholders at 07:00 a.m. CEST and hosting an English-speaking Analyst and Media Conference at 10:00 a.m. CEST at Zunfthaus zur Saffran, Limmatquai 54, 8001 Zürich/Switzerland. Please register for the live Zürich conference by email to lifewatch@sensus.ch. The conference is also accessible as a conference call/webcast at:

+ 41 (0)91 610 56 00 (Europe); + 44 (0)207 107 06 11 (UK); + 1(1)866 291 41 66 (USA - Toll-free);

http://www.irlifewatch.com

About LifeWatch AG:

LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on SIX Swiss Exchange (LIFE), Switzerland, is the leading healthcare technology and solution company, specializing in advanced telehealth systems and wireless remote patient monitoring services. LifeWatch services cater to individuals, ranging from high-risk and chronically ill patients, to consumers of health and wellness products. LifeWatch has subsidiaries in the United States, the Netherlands, Japan, the United Kingdom, Switzerland and Israel. LifeWatch AG is the parent company of LifeWatch Services Inc., a leading US-based cardiac monitoring service provider, and manufacturer of telecardiology products. LifeWatch is also introducing a new program for Home SleepTesting of Obstructive Sleep Apnea (OSA) patients under the brand name NiteWatch. For additional information, please visit www.lifewatch.com.

Sign-up for customized E-mail alerts and documentation requests is available at http://production.investis.com/lifewatch/alert-service/

@@start.t2@@end of announcement                                                 euro adhoc
--------------------------------------------------------------------------------@@end@@

ots Originaltext: LifeWatch AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:
Woo Kim, Senior Vice President of Strategy and Business Development, LifeWatch
Tel +1 847 813 4299 | Fax +1 847 813 24 48 | Email wkim@lifewatch.com

Sensus Investor and Public Relations, Zürich:
Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | Email lifewatch@sensus.ch

Branche: Healthcare Providers
ISIN:      CH0012815459
WKN:        1281545
Index:    SPI, SPIEX
Börsen:  Frankfurt / Open Market / XETRA
              Berlin / free trade
              SIX Swiss Exchange / Main Standard



Weitere Meldungen: LifeWatch AG

Das könnte Sie auch interessieren: